The PI3K-Akt pathway has shown therapeutic and preventive effects in various neurological disorders including stroke, Alzheimer’s disease, and Parkinson’s disease [60, 61]. This evidence concerns the gene AKT1 and early-onset autosomal dominant Alzheimer disease.